火箭-miR,一个基于miRNA的抗微生物药物开发的翻译发射台
Samuel L Neff1, Thomas H Hampton1, Katja Koeppen1
1Department of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.
mSystems
|November 17, 2023
概括
抗微生物耐药性是一种全球性威胁. 火箭-miR应用程序有助于研究人员发现基于miRNA的新型抗菌药物来对抗具有挑战性的细菌和真菌病原体.
科学领域:
- 微生物学 微生物学
- 生物信息学是一种生物信息学.
- 药物发现 药物发现 药物发现
背景情况:
- 抗生素耐药性感染每年导致数百万人的死亡.
- 逃跑的病原体 (菌菌,金黄色葡萄球菌,肺炎菌,宝曼菌, Pseudomonas aeruginosa 和 Enterobacter sp.) 没有被发现. 由于耐药性,它们是一个重大问题.
- 新型抗菌疗法对于治疗耐药性感染至关重要.
研究的目的:
- 引入Rocket-miR应用程序,用于识别潜在的miRNA基抗菌剂.
- 支持微生物学家在发现新的抗微生物药物的过程中.
- 为针对24种人类病原体提供一个平台,并可扩展到其他病原体.
主要方法:
- 火箭-miR应用程序预测了人类微RNA (miRNA) 在细菌和真菌病原体中的目标.
- 该应用程序有助于快速识别基于miRNA的候选抗菌药物.
- 代码库被设计为易于扩展,包括额外的人类病原体.
主要成果:
- 火箭-miR可以快速识别候选抗微生物miRNAs.
- 该应用程序支持24个关键的人类病原体与肺炎和尿道感染等疾病相关.
- 该平台可以适应新出现的医院感染.
结论:
- 火箭-miR是加速发现基于miRNA的抗微生物药物的宝贵工具.
- 该申请解决了对抗抗菌素耐药性的新治疗方法的迫切需要.
- 它的可扩展设计支持对新型抗菌战略的持续研究.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:29Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35